Search
forResearch 10 of 355
- Papulopustular eruptions associated with EGFR-pathway-related targeted therapies: clinical spectrum, evidence boundaries, folliculocentric inflammation, and management considerations
- A linear and reticulate crusted keratotic papulopustular eruption: a rare presentation of PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) complex
- Histopathologic features of erythematous papulopustular eruption to epidermal growth factor receptor inhibitors in cancer patients
- Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs
- 176 Hair eruption initiates adverse events of EGFR-targeted cancer therapy
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →